Cardio Diagnostics Holdings, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses), averaging +56.8% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | not reported | $-0.51 | not reported | not reported | |
| Q1 FY26 | not reported | $-0.63 | not reported | not reported | |
| Q4 FY25 | not reported | $-0.80 | not reported | not reported | |
| Q3 FY25 | not reported | $-0.98 | not reported | not reported | |
| Q2 FY25 | not reported | $-0.97 | not reported | not reported | |
| Q1 FY25 | not reported | $-0.97 | not reported | not reported | |
| Q3 FY24 | $-0.15 | $-0.06 | +60.0% | Beat | |
| Q2 FY24 | $-0.13 | $-0.06 | +53.9% | Beat | |
| Q3 FY23 | $-0.39 | $-0.17 | +56.4% | Beat |
Back to CDIO overview · CDIO holders · CDIO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.